In a recent study, GSC-005 glioblastoma-bearing mice treated intratumorally with Delta-24-RGDOX, an engineered oncolytic adenovirus with an OX-40L expression cassette, exhibited distinct gut microbiota changes. Here, TNFSF4 is linked to glioblastoma.